Clinical Scorecard: Comparative Analysis of Real-World Efficacy of Medication-Assisted Treatment and Psychotherapy for Opioid Use Disorder: Insights from a National Multi-Healthcare Organization Study

At a Glance

Key Highlights

• Both MOUD (buprenorphine, methadone) and psychotherapy independently increase remission rates compared to no treatment
• Combination of buprenorphine plus psychotherapy yields the highest remission benefit (adjusted hazard ratio 5.26)
• Anxiety diagnoses and gabapentinoid prescriptions are positively associated with remission; benzodiazepine co-prescription is negatively associated

Guideline-Based Recommendations

Diagnosis

• Use ICD-10 code F11.20 to identify opioid dependence
• Consider psychiatric comorbidities such as anxiety when assessing treatment plans

Management

• Implement MOUD with buprenorphine or methadone as first-line pharmacologic treatments
• Incorporate structured psychotherapy sessions (30–60 minutes) to enhance treatment outcomes
• Combine MOUD and psychotherapy to maximize remission likelihood

Monitoring & Follow-up

• Track remission status using ICD-10 codes F11.21 and F11.11 within 12 months
• Monitor co-prescriptions, especially benzodiazepines, due to negative association with remission

Risks

• Benzodiazepine co-prescription may reduce remission rates and increase risk
• Stigma and policy barriers limit access to evidence-based treatments

Patient & Prescribing Data

Adults aged 18–45 with opioid dependence across 112 U.S. health systems

MOUD and psychotherapy independently improve remission; combined treatment shows additive benefits; co-prescription patterns influence outcomes

Clinical Best Practices

• Prioritize access to both MOUD and behavioral health supports for comprehensive harm reduction
• Tailor treatment plans considering psychiatric comorbidities and medication interactions
• Use multimodal approaches integrating pharmacologic and psychosocial interventions
• Leverage large-scale EHR data to inform real-world treatment effectiveness and guide policy

References

• TriNetX Research Network